J Deakin1, C O'Loughlin. Show Affiliations » 1. Fulbourn Hospital, Cambridge, UK. juliabrynja@gmail.com
Abstract
Mesh： See more » Antidepressive Agents/administration & dosageAntidepressive Agents/adverse effectsAntidepressive Agents/therapeutic useAntidepressive Agents, Second-Generation/administration & dosageAntidepressive Agents, Second-Generation/adverse effectsAntidepressive Agents, Second-Generation/therapeutic useCognitive Behavioral TherapyDepressive Disorder/drug therapyDepressive Disorder/therapyDrug Prescriptions/statistics & numerical dataDrug Therapy, CombinationHumansMonoamine Oxidase Inhibitors/administration & dosageMonoamine Oxidase Inhibitors/adverse effectsMonoamine Oxidase Inhibitors/therapeutic useRandomized Controlled Trials as TopicResearch DesignTreatment OutcomeUnited Kingdom
Substances： See more » Antidepressive AgentsAntidepressive Agents, Second-GenerationMonoamine Oxidase Inhibitors
Year: 2009 PMID： 19395428 DOI： 10.1177/0269881109104886
Source DB: PubMed Journal: J Psychopharmacol ISSN： 0269-8811 Impact factor: 4.153